Ribas et al also found that AR could directly bind to miR-21 promoter to exert its influence on the prostate cancer growth [30], and Murata et al reported that miR-148a was an androgen-responsive miRNA that could promote prostate LNCaP cell growth via repressing its target CAND1 expression [20]. The gene discussed is CAND1; the disease is prostate carcinoma.